The Effect of a Novel Taurine Nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour Ea (TCNU) on Cytotoxicity, DNA Crosslinking and Glutathione Reductase in Lung Carcinoma Cell Lines

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1987 Jan 1

PMID 2954712

Citations 1

Authors

K D Tew

S W Dean

N W Gibson

Affiliations

Soon will be listed here.

Abstract

A novel nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosourea (TCNU) has been investigated with respect to cytotoxic mechanisms in rat and human cell lines which either possess (Mer+) or lack (Mer-) 0(6)-alkylguanine transferase activity. TCNU produced significantly greater cytotoxicity in the Mer- cells (Walker 256 rat breast carcinoma resistant to nitrogen mustards; human lung carcinoma A427) than in the Mer+ cells (Walker 256 wild-type; human lung carcinoma A594). This correlated with results generated by alkaline elution studies which showed that TCNU caused DNA interstrand crosslinks in A427 but not in A549 cells. Inhibition of glutathione reductase activity by TCNU demonstrated that in carbamoylating activity the drug was intermediate between chlorozotocin and 1,(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in both A427 and A549 cells. These data suggest that the presence of taurine in the drug structure does little to alter the cytotoxicity or the alkylating or carbamoylating properties of TCNU, and that any clinical advantages with TCNU will be the consequence of other factors.

Citing Articles

Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).

Christensson P, Gunnarsson K, Gunnarsson P, Jensen G, Polacek J, Stamvik A Invest New Drugs. 1988; 6(1):19-30.

PMID: 3410663 DOI: 10.1007/BF00170775.

References

TALLAN H, Jacobson E, Wright C, SCHNEIDMAN K, Gaull G . Taurine uptake by cultured human lymphoblastoid cells. Life Sci. 1983; 33(19):1853-60. DOI: 10.1016/0024-3205(83)90669-0. View

Wakayama K, Besa E, Baskin S . Changes in intracellular taurine content of human leukemic cells. Nagoya J Med Sci. 1983; 45(3-4):89-96. View

CHRISTENSEN H, Hess B, RIGGS T . Concentration of taurine, beta-alanine, and triiodothyronine by ascites carcinoma cells. Cancer Res. 1954; 14(2):124-7. View

Babson J, Reed D . Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates. Biochem Biophys Res Commun. 1978; 83(2):754-62. DOI: 10.1016/0006-291x(78)91053-7. View

Ishidate M, Sakurai Y, Izumi M . N-Bis (beta-chloroethyl) amino acids and related compounds as tumor-growth retarding agents. J Am Pharm Assoc Am Pharm Assoc. 1955; 44(3):132-5. DOI: 10.1002/jps.3030440303. View

MIZE C, Langdon R . Hepatic glutathione reductase. I. Purification and general kinetic properties. J Biol Chem. 1962; 237:1589-95. View

Smith A, Boyd M . Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity. J Pharmacol Exp Ther. 1984; 229(3):658-63. View

Dean S, Gibson N, Tew K . Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity. Mol Pharmacol. 1986; 30(1):77-80. View

Tew K, Kyle G, Johnson A, Wang A . Carbamoylation of glutathione reductase and changes in cellular and chromosome morphology in a rat cell line resistant to nitrogen mustards but collaterally sensitive to nitrosoureas. Cancer Res. 1985; 45(5):2326-33. View

10.

Erickson L, Bradley M, Ducore J, Ewig R, Kohn K . DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc Natl Acad Sci U S A. 1980; 77(1):467-71. PMC: 348292. DOI: 10.1073/pnas.77.1.467. View

11.

Tokunaga H, Yoneda Y, Kuriyama K . Protective actions of taurine against streptozotocin-induced hyperglycemia. Biochem Pharmacol. 1979; 28(18):2807-11. DOI: 10.1016/0006-2952(79)90566-5. View

12.

Pierson H, Fisher J, Rabinovitz M . Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity. J Natl Cancer Inst. 1985; 75(5):905-9. DOI: 10.1093/jnci/75.5.905. View

13.

Tew K, Wang A . Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards. Mol Pharmacol. 1982; 21(3):729-38. View